Search
for
Sort by
Research 211–240 of 227
- A Rare Case of Steroid Cell Tumor, Not Otherwise Specified (NOS), of the Ovary in a Young Woman
- Care Considerations and Management of Transgender Individuals After Kidney Transplantation: A Single Institution Experience and Literature Review
- Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome
- Obstructive Sleep Apnea Due to Endogenous Testosterone Production in a Woman
- Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients
- Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint II. Role of progesterone metabolites
- IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Affirmation as Male
- Isochromosome Mosaic Turner Syndrome: A Case Report
- The Role of the Athletic Trainer in Providing Care to Transgender and Gender-Diverse Patients: Considerations for Medical Affirmation—Part II
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Green and Emerging Microextraction Strategies for Bioanalytical Determination of Hormones: Trends, Challenges, and Applications
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- Myo-Inositol (ProFecund Ino) – Obtaining a Pregnancy in Women with Polycystic Ovary Syndrome
- Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update
- ZALCITABINE
- Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective
- Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome
- Treatment of alopecia X with medroxyprogesterone acetate
- Medroxyprogesterone acetate therapy in hirsutism
- Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
- Treatment of idiopathic facial hirsutism with medroxyprogesterone acetate iontophoresis
- PROGRESSIVE SLEEP APNOEAS RESPOND TO MEDROXYPROGESTERONE ACETATE
- The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial
- Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- PHARMACOVIGILANCE STUDY OF SIDE EFFECTS ASSOCIATED WITH LEVONORGESTROL -ETHINYL ESTRADIOL AND DEPOTMEDROXY PROGESTERONE ACETATE
- Side effects of androgen deprivation therapy: monitoring and minimizing toxicity
- Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy